Recombinant Newcastle Disease Virus Encoding IL-12 and/or IL-2 as Potential Candidate for Hepatoma Carcinoma Therapy

Recombinant Newcastle Disease virus Expressing IL15 Demonstrates Promising Antitumor Efficiency in Melanoma Model

(2015) Zeshan Niu et al.   TECHNOLOGY IN CANCER RESEARCH & TREATMENT

Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy

(2014) Fu-Liang Bai et al.   CANCER BIOLOGY & THERAPY

Interleukin 12: still a promising candidate for tumor immunotherapy?

(2014) Witold Lasek et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy

(2014) D. Zamarin et al.   Science Translational Medicine

TNF-related Apoptosis-inducing Ligand Delivered by rNDV is a Novel Agent for Cancer Gene Therapy

(2014) Fu-Liang Bai et al.   TECHNOLOGY IN CANCER RESEARCH & TREATMENT

Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy

(2013) Wei Liao et al.   IMMUNITY

Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions

(2012) Dmitriy Zamarin et al.   Future Microbiology

Interleukin-12: Clinical usage and molecular markers of cancer susceptibility

(2012) Arseniy E. Yuzhalin et al.   GROWTH FACTORS

Cutting Edge: A Novel Mechanism Bridging Innate and Adaptive Immunity: IL-12 Induction of CD25 To Form High-Affinity IL-2 Receptors on NK Cells

(2012) S.-H. Lee et al.   JOURNAL OF IMMUNOLOGY

IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation

(2011) Wei Liao et al.   CURRENT OPINION IN IMMUNOLOGY

Selective Cytotoxicity of Goniothalamin against Hepatoblastoma HepG2 Cells

(2011) Mothanna Al-Qubaisi et al.   MOLECULES

Antitumor efficacy of viral therapy using genetically engineered Newcastle disease virus [NDV(F3aa)-GFP] for peritoneally disseminated gastric cancer

(2010) Kyo Young Song et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Engineered Newcastle Disease Virus as an Improved Oncolytic Agent Against Hepatocellular Carcinoma

(2009) Jennifer Altomonte et al.   MOLECULAR THERAPY

Recombinant Newcastle Disease Virus as a Vaccine Vector for Cancer Therapy

(2008) Adam Vigil et al.   MOLECULAR THERAPY

Recombinant Newcastle disease virus expressing human interleukin-2 serves as a potential candidate for tumor therapy

(2008) Heng Zhao et al.   VIRUS RESEARCH

Synergistic effects of IL-2, IL-12 and IL-18 on cytolytic activity, perforin expression and IFN-γ production of porcine natural killer cells

(2007) Maša Pintarič et al.   VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY